Benzinga | Feb 12, 2021 07:29AM EST

Raymond James Maintains Outperform on DexCom, Raises Price Target to $449

Raymond James analyst Jayson Bedford maintains DexCom (NASDAQ:DXCM) with a Outperform and raises the price target from $415 to $449.